NCT01675284View on ClinicalTrials.gov

A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Bird FluAvian InfluenzaInfluenza A(H5N1)
Interventions
BIOLOGICAL

AT-301

Inactivated H5N1 Influenza Virion Vaccine

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Medigen Biotechnology Corporation

INDUSTRY